Total Costs & Expenses

$1.22B

Quarterly · Period ending: Jun 30, 2026 · USD

EW Total Costs & Expenses

Latest reported$1.22Bperiod endingJun 30, 2026

EW Quarterly Total Costs & Expenses ($209.00M → $1.22B)

Quarterly Total Costs & Expenses

High-resolution chart · PNG

EW total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences Total Costs & Expenses — Quarterly (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2026	1,221,500,000
Mar 31, 2026	1,133,900,000
Dec 31, 2025	1,199,300,000
Sep 30, 2025	1,128,000,000
Jun 30, 2025	1,101,300,000
Mar 31, 2025	1,017,900,000
Dec 31, 2024	1,073,200,000
Sep 30, 2024	1,003,800,000
Jun 30, 2024	1,021,200,000
Mar 31, 2024	974,400,000
Dec 31, 2023	909,700,000
Sep 30, 2023	896,900,000
Jun 30, 2023	924,900,000
Mar 31, 2023	1,056,800,000
Dec 31, 2022	938,800,000
Sep 30, 2022	891,800,000
Jun 30, 2022	945,500,000
Mar 31, 2022	905,500,000
Dec 31, 2021	967,900,000
Sep 30, 2021	903,000,000
Jun 30, 2021	925,400,000
Mar 31, 2021	825,800,000
Dec 31, 2020	829,400,000
Sep 30, 2020	789,900,000
Jun 30, 2020	703,800,000
Mar 31, 2020	767,200,000
Dec 31, 2019	837,000,000
Sep 30, 2019	807,500,000
Jun 30, 2019	816,200,000
Mar 31, 2019	691,400,000
Dec 31, 2018	687,600,000
Sep 30, 2018	651,200,000
Jun 30, 2018	661,500,000
Mar 31, 2018	630,200,000
Dec 31, 2017	647,100,000
Sep 30, 2017	603,500,000
Jun 30, 2017	587,000,000
Mar 31, 2017	575,900,000
Dec 31, 2016	558,800,000
Sep 30, 2016	540,600,000
Jun 30, 2016	544,200,000
Mar 31, 2016	495,400,000
Dec 31, 2015	496,400,000
Sep 30, 2015	459,700,000
Jun 30, 2015	470,000,000
Mar 31, 2015	424,900,000
Dec 31, 2014	467,500,000
Sep 30, 2014	477,900,000
Jun 30, 2014	455,800,000
Mar 31, 2014	428,900,000
Dec 31, 2013	414,600,000
Sep 30, 2013	394,300,000
Jun 30, 2013	394,900,000
Mar 31, 2013	387,200,000
Dec 31, 2012	378,600,000
Sep 30, 2012	353,300,000
Jun 30, 2012	386,200,000
Mar 31, 2012	373,100,000
Dec 31, 2011	343,700,000
Sep 30, 2011	352,800,000
Jun 30, 2011	355,900,000
Mar 31, 2011	326,100,000
Dec 31, 2010	311,800,000
Sep 30, 2010	281,500,000
Jun 30, 2010	291,600,000
Mar 31, 2010	277,800,000
Dec 31, 2009	282,300,000
Sep 30, 2009	269,100,000
Jun 30, 2009	273,000,000
Mar 31, 2009	258,800,000
Dec 31, 2008	254,800,000
Sep 30, 2008	259,300,000
Jun 30, 2008	274,900,000
Mar 31, 2008	262,100,000
Dec 31, 2007	247,600,000
Sep 30, 2007	224,800,000
Jun 30, 2007	225,500,000
Mar 31, 2007	219,500,000
Dec 31, 2006	222,500,000
Sep 30, 2006	207,200,000
Jun 30, 2006	221,600,000
Mar 31, 2006	191,000,000
Dec 31, 2005	202,500,000
Sep 30, 2005	200,800,000
Jun 30, 2005	212,200,000
Mar 31, 2005	206,500,000
Dec 31, 2004	197,300,000
Sep 30, 2004	189,500,000
Jun 30, 2004	194,100,000
Mar 31, 2004	211,600,000
Dec 31, 2003	185,000,000
Sep 30, 2003	174,200,000
Jun 30, 2003	186,700,000
Mar 31, 2003	179,500,000
Dec 31, 2002	172,100,000
Sep 30, 2002	206,700,000
Jun 30, 2002	141,700,000
Mar 31, 2002	131,400,000
Dec 31, 2001	132,900,000
Sep 30, 2001	124,500,000